Literature DB >> 28791598

Opioid Medications in the Management of Chronic Abdominal Pain.

Dajie Wang1.   

Abstract

PURPOSE OF REVIEW: Chronic abdominal pain is a complex medical condition. The causes of chronic abdominal pain are extremely diverse ranging from chronic pancreatitis, Crohn's disease, to chronic pain with no clear etiology. Treatment of chronic abdominal pain remains a challenge in our clinical practice. While current interventions with celiac plexus blocks and pain medications provide some relief for these patients, but these treatments are typically less efficacious and limited by various adverse effects. Opioid medications are commonly used to manage chronic pain syndromes that are refectory to other pain management interventions. The potential problems related to opioids include misuse, abuse, constipation, nausea pruritus, et al. Moreover, according to the recent centers for disease (CDC) control report, opioid abuse has reached epidemic proportions in the USA (LJ P. Centers for Disease Control and Prevention. 2016) and accounted for 28,000 deaths in 2014. Rudd et al. (MMWR Morb Mortal Wkly Rep 64(50-51):1378-82, 2016) Given this current situation, it is apparent that a careful review of clinical evidences supporting the use of opioid medications is necessary to guide our treatment approaches in the management of complex chronic abdominal pain patients. This review is set out to analyze efficacy of opioid medications for chronic abdominal pain. RECENT
FINDINGS: The literature referenced was obtained via a computer search with Google Scholar, Pubmed, Medline, and EMbase. The search terms used included Opioid, Oxycodone, Buprenorphine, Morphine, Fentanyl, Oxymorphone, Hydromorphone, chronic abdominal pain, Crohn's disease, and pancreatitis. All studies were considered eligible for inclusion if they were clinical studies evaluating the efficacy of opioid medications for chronic abdominal pain. Two studies were found according to these criteria. Chronic abdominal pain is a challenging medical condition in our daily practice. This condition often requires opioid medications when other treatments fail. This review provided very limited clinical evidence to support long-term opioid use for chronic abdominal pain. Given recent CDC report of opioid epidemic, it is prudent to use the best medical practice with appropriate evaluation of psychological comorbidities, urine drug screening, prescription drug monitor, and opioid treatment agreements to minimize adverse side effects related to opioids. Furthermore, well-designed clinical trials are needed to evaluate the effectiveness of long-term use of opioid medications, and more clinical research on which opioid medication is more effective for chronic abdominal pain.

Entities:  

Keywords:  Abdominal pain; Chronic abdominal pain; Chronic pancreatitis; Crohn’s disease; Opioid medications; Opioids

Mesh:

Substances:

Year:  2017        PMID: 28791598     DOI: 10.1007/s11916-017-0640-x

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  45 in total

Review 1.  Opioid contracts in chronic nonmalignant pain management: objectives and uncertainties.

Authors:  Robert M Arnold; Paul K J Han; Deborah Seltzer
Journal:  Am J Med       Date:  2006-04       Impact factor: 4.965

2.  Chronic narcotic use in inflammatory bowel disease patients: prevalence and clinical characteristics.

Authors:  J T Edwards; G L Radford-Smith; T H Florin
Journal:  J Gastroenterol Hepatol       Date:  2001-11       Impact factor: 4.029

Review 3.  The narcotic bowel syndrome: a recent update.

Authors:  Douglas Drossman; Eva Szigethy
Journal:  Am J Gastroenterol Suppl       Date:  2014-09-10

4.  Drug poisoning deaths in the United States, 1980-2008.

Authors:  Margaret Warner; Li Hui Chen; Diane M Makuc; Robert N Anderson; Arialdi M Miniño
Journal:  NCHS Data Brief       Date:  2011-12

Review 5.  Opioids for acute pancreatitis pain.

Authors:  Xavier Basurto Ona; David Rigau Comas; Gerard Urrútia
Journal:  Cochrane Database Syst Rev       Date:  2013-07-26

6.  Mental illness and psychotropic drug use among prescription drug overdose deaths: a medical examiner chart review.

Authors:  Robin L Toblin; Leonard J Paulozzi; Joseph E Logan; Aron J Hall; James A Kaplan
Journal:  J Clin Psychiatry       Date:  2010-04       Impact factor: 4.384

7.  Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study.

Authors:  Camilla Staahl; Georg Dimcevski; Søren Due Andersen; Niels Thorsgaard; Lona L Christrup; Lars Arendt-Nielsen; Asbjørn Mohr Drewes
Journal:  Scand J Gastroenterol       Date:  2007-03       Impact factor: 2.423

8.  Opioid prescriptions by U.S. primary care physicians from 1992 to 2001.

Authors:  Yngvild Olsen; Gail L Daumit; Daniel E Ford
Journal:  J Pain       Date:  2006-04       Impact factor: 5.820

9.  Pancreatic duct pressure in chronic pancreatitis.

Authors:  E L Bradley
Journal:  Am J Surg       Date:  1982-09       Impact factor: 2.565

10.  Opioid use is associated with decreased quality of life in patients with Crohn's disease.

Authors:  David Sanford; Patrick Thornley; Anouar Teriaky; Nilesh Chande; James Gregor
Journal:  Saudi J Gastroenterol       Date:  2014 May-Jun       Impact factor: 2.485

View more
  6 in total

1.  Factors Associated With Frequent Opioid Use in Children With Acute Recurrent and Chronic Pancreatitis.

Authors:  Emily R Perito; Tonya M Palermo; John F Pohl; Maria Mascarenhas; Maisam Abu-El-Haija; Bradley Barth; Melena D Bellin; Douglas S Fishman; Steven Freedman; Cheryl Gariepy; Matthew Giefer; Tanja Gonska; Melvin B Heyman; Ryan W Himes; Sohail Z Husain; Tom Lin; Quin Liu; Asim Maqbool; Brian McFerron; Veronique D Morinville; Jaime D Nathan; Chee Y Ooi; Sue Rhee; Sarah Jane Schwarzenberg; Uzma Shah; David M Troendle; Steven Werlin; Michael Wilschanski; Yuhua Zheng; Miriam Bridget Zimmerman; Mark Lowe; Aliye Uc
Journal:  J Pediatr Gastroenterol Nutr       Date:  2020-01       Impact factor: 2.839

Review 2.  Current overview of opioids in progression of inflammatory bowel disease; pharmacological and clinical considerations.

Authors:  Naser-Aldin Lashgari; Nazanin Momeni Roudsari; Nadia Zandi; Benyamin Pazoki; Atiyeh Rezaei; Mehrnoosh Hashemi; Saeideh Momtaz; Roja Rahimi; Maryam Shayan; Ahmad Reza Dehpour; Amir Hossein Abdolghaffari
Journal:  Mol Biol Rep       Date:  2021-01-04       Impact factor: 2.316

Review 3.  Toward an effective peripheral visceral analgesic: responding to the national opioid crisis.

Authors:  Michael Camilleri
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-02-22       Impact factor: 4.052

Review 4.  Focus on current and future management possibilities in inflammatory bowel disease-related chronic pain.

Authors:  Anna Zielińska; Maciej Sałaga; Marcin Włodarczyk; Jakub Fichna
Journal:  Int J Colorectal Dis       Date:  2018-12-19       Impact factor: 2.571

5.  Sacral nerve stimulation with optimized parameters improves visceral hypersensitivity in rats mediated via the autonomic pathway.

Authors:  Liuqin Jiang; Nina Zhang; Shengai Zhang; Jiande Dz Chen
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

Review 6.  Utilization of Intravenous Lidocaine Infusion for the Treatment of Refractory Chronic Pain.

Authors:  Janell Tully; Jai Won Jung; Anjana Patel; Alyson Tukan; Sameer Kandula; Allen Doan; Farnad Imani; Giustino Varrassi; Elyse M Cornett; Alan David Kaye; Omar Viswanath; Ivan Urits
Journal:  Anesth Pain Med       Date:  2021-01-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.